GBD 2019: Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050
2022
This article from The Lancet Public Health estimates the global prevalence of dementia using data from the Global Burden of Disease (GBD) Study 2019. This paper seeks to provide policymakers and health officials an understanding of the health challenges the globe or their individual countries face, as well as how these challenges change over time. The GBD papers incorporate the prevalence of a disease, injury, or risk factor and the relative harm they cause to align health systems with the populations they serve.
Led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, GBD is a global effort with researchers from over 150 countries and territories. IHME and other partnering organizations have developed numerous resources to disseminate and visualize the findings of the GBD studies, data visualizations and interactives, country profiles, policy reports, research articles, infographics, and the GBD Results Tool, which allows users to search GBD data.
GBD 2019: Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050
Source:
Nichols E et al. Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019. The Lancet Public Health 2022; Online First: 1-21.
DOI: https://doi.org/10.1016/S2468-2667(21)00249-8.